Your industry news - first
Diversey acquires AHP Intellectual Property from Virox Technologies
Diversey has acquired the global intellectual property rights related to Accelerated Hydrogen Peroxide technology, from Virox Technologies.
AHP is a globally patented blend of commonly used ingredients that produces exceptional potency as a germicide and superior performance as a cleaning agent.
AHP has proven to be a fast, effective, responsible and sustainable solution.
Each year, healthcare-associated infections and food-borne illnesses impact millions. Over the past decade, Diversey and Virox have partnered to develop a number of AHP-based solutions, including leading brands Oxivir, Accel, and Viper.
In the last few years, Diversey has invested significantly to build leadership positions in healthcare and infection prevention through thought leadership, innovation and evidence-based product and practice development. This acquisition supports Diversey's mission to reduce preventable infections, control associated costs, and ultimately help save lives.
"With a mission to protect and care for people every day, infection prevention is a major focus for Diversey," says Mark Burgess, CEO of Diversey. “Adding this intellectual property to our portfolio will enhance our ability to accelerate innovation and grow our position in infection prevention globally. It will inform our future investment decisions as we continue to apply science to protect people every day.
This major acquisition reaffirms Diversey's global commitment to achieve profitable growth through innovation and acquisition."
Diversey will continue to license this technology to partners where this innovative solution can be used to deliver value across other markets.
9th January 2020